FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2024
Back to search
Official data from USPTO
RBGALSTAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RBGALSTAR
ST13
US500000079351185Class
1, 5, 42
Filing
79351185
Registration
7341611
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/02/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
07/15/2022
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
CN
Examiner
LAVACHE, LINDA M
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Suzhou Ribo Life Science Co., Ltd.
Representatives
Hamre Schumann Muller & Larson, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicalsglucosides; carbonic hydrates; polymer resinsunprocessed; artificial resinsunprocessed; chemical preparations in the nature of ion-exchange resins; enzymes for industrial purposes; enzymes for the food industry; biochemical catalysts; industrial chemicals; chemical preparations for scientific purposesother than for medical or veterinary use
Class 5
Medicines for humans for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; pharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; drugs for medical purposespharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; biological preparations for medical purposes for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; chemical preparations for pharmaceutical purposes for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; chemical preparations for medical purposes for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; crude drugs being pharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of infectious diseases; diagnostic preparations for medical purposes; dietetic substances adapted for medical usedietary supplements and dietetic foods adapted for medical use; depuratives for the body; pharmaceutical preparations for the treatment of hypercholesteremia; pesticides; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; medicines for veterinary purposes for the treatment of gastrointestinal diseases and condition; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dressingsmedical; composite materials for dental purposes; diapers for pets
Class 42
Technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; quality control for others; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemistry research services; medical and scientific researchconducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/16/2024
FIMP
FINAL DISPOSITION PROCESSED
10/16/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/25/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/06/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2023
RFNP
REFUSAL PROCESSED BY IB
07/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/15/2023
RFRR
REFUSAL PROCESSED BY MPU
06/14/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/05/2023
CNRT
NON-FINAL ACTION WRITTEN
05/04/2023
DOCK
ASSIGNED TO EXAMINER
05/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/29/2022
Continuous trademark protection
Get notified about every new filing that threatens RBGALSTAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.